Recordati Industria Chimica e Farmaceutica SpA
OTC:RCDTF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
OTC:RCDTF
|
IT |
|
Getty Realty Corp
F:GRL
|
US |
|
Subsea 7 SA
OSE:SUBC
|
UK |
Wall St Price Targets
RCDTF Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA
According to Wall Street analysts, the average 1-year price target for
RCDTF is 67.91 USD with a low forecast of 54.81 USD and a high forecast of 84.29 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RCDTF's stock price target?
Price Target
67.91
USD
According to Wall Street analysts, the average 1-year price target for
RCDTF is 67.91 USD with a low forecast of 54.81 USD and a high forecast of 84.29 USD.
What is the Revenue forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 20%.